MYRX

Myrexis, Inc. [MYRX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

MYRX Stock Summary

Top 10 Correlated Stocks

MYRX

In the News

MYRX Financial details

Company Rating
-
Market Cap
4.14M
Income
-11.62M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-0.32
Quick Ratio
16.35
Current Ratio
16.72
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.42
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-939%
ROE
-26%
ROC
-10.31%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.0E-4-0.0192
52W High
-
52W Low
-
RSI
37.34
Rel Volume
0.04
Avg Volume
944
Volume
37
Perf Week
-12.5%
Perf Month
0%
Perf Quarter
6.06%
Perf Half Y
6.06%
-
-
-
-
Beta
1.365
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.007
Change
0%

Something similar

Top by Market Cap
TL0.DE
GOOG
NVDA
CMC.DE
AMZ.DE
Same Sector
TTP.TO
VBAL.TO
XLF
PRIUX
XIEE.DE
Top Correlated Stocks
4975.T
CLCS
3687.T
4099.T
7270.T
Similar Market Cap
REDW.ST
GEEXW
FAME
BOD.L
CNSP

Company Profile

Financial Services Shell Companies
  • Volume Average 944
  • Market Capitalization 4.14M
  • Employee 1
  • CEO Mr. Jonathan M. Couchman
  • Headquarters New York,NY,US
  • IPO Date 2009-06-12
  • Website https://www.myrexis.com

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.